SAB Biotherapeutics

Lori Walsh

In The Moment ... June 8, 2018 Show 354 Hour 2

The USD Discovery District has its first anchor tenant - SAB Biotherapeutics, Inc.  SAB president, CEO and co-founder Eddie Sullivan talks about being the first tenant and shares his goals for the first project.  He's joined by Rich Naser, president of the USD Discovery District.

Melissa Ullerich

Ag Innovation is the focus of a panel conversation during the Governor’s Ag Summit in Aberdeen. Other topics include animal health, economics and succession planning.  The annual event brings awareness to the economic potential of agriculture in South Dakota.

Jerry Pommer is the Chief Compliance Officer of SAb Biotherapeutics.  He says the company's research project, DiversitAb, uses genetically-designed cattle to produce human antibodies against global diseases.

SAB Biotherapeutics, Inc.

Eddie Sullivan is the President, CEO and Co-Founder of SAB Biotherapeutics, Inc. based in Sioux Falls. The biopharmaceutical company leads the science and manufacturing of polyclonal antibody therapies. Eddie Sullivan has been named chair of the food and agriculture section governing board for the Biotechnology Innovation Organization or Bio. It’s the industry’s largest international trade association.